• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cytotoxic and antimicrobial activities of secondary metabolites isolated from the deep-sea-derived 12A22.从深海来源的12A22中分离出的次生代谢产物的细胞毒性和抗菌活性。
3 Biotech. 2021 Jun;11(6):283. doi: 10.1007/s13205-021-02846-0. Epub 2021 May 21.
2
Identification of antimicrobial compound, diketopiperazines, from a Bacillus sp. N strain associated with a rhabditid entomopathogenic nematode against major plant pathogenic fungi.从与植物病原真菌拮抗的杆状菌 N 菌株中鉴定出抗菌化合物二酮哌嗪
J Appl Microbiol. 2012 Oct;113(4):914-24. doi: 10.1111/j.1365-2672.2012.05385.x. Epub 2012 Jul 25.
3
Antimicrobial Potential of Endophytic Fungi From and Bioactive Metabolites From sp. AC1.来自[具体来源未提及]的内生真菌的抗菌潜力以及来自[具体菌种未提及]AC1的生物活性代谢产物。
Front Microbiol. 2022 Jun 23;13:908836. doi: 10.3389/fmicb.2022.908836. eCollection 2022.
4
Actinoalloteichus cyanogriseus gen. nov., sp. nov.蓝灰动双孢放线菌,新属,新种
Int J Syst Evol Microbiol. 2000 Jul;50 Pt 4:1435-1440. doi: 10.1099/00207713-50-4-1435.
5
Antimicrobial gageomacrolactins characterized from the fermentation of the marine-derived bacterium Bacillus subtilis under optimum growth conditions.从海洋来源的枯草芽孢杆菌在最佳生长条件下的发酵中得到的抗微生物大内酯。
J Agric Food Chem. 2013 Apr 10;61(14):3428-34. doi: 10.1021/jf4009229. Epub 2013 Mar 25.
6
Taxonomic study and partial characterization of antimicrobial compounds from a moderately halophilic strain of the genus Actinoalloteichus.分类学研究及中度嗜盐放线菌属 Actinoalloteichus 中抗菌化合物的部分特性鉴定。
Braz J Microbiol. 2011 Jul;42(3):835-45. doi: 10.1590/S1517-83822011000300002. Epub 2011 Sep 1.
7
Cytotoxic bipyridines from the marine-derived actinomycete Actinoalloteichus cyanogriseus WH1-2216-6.海洋来源放线菌 Actinoalloteichus cyanogriseus WH1-2216-6 中的细胞毒性联吡啶。
J Nat Prod. 2011 Aug 26;74(8):1751-6. doi: 10.1021/np200258h. Epub 2011 Jul 19.
8
Identification of antimicrobial metabolites produced by a potential biocontrol Actinomycete strain A217.鉴定潜在生防放线菌菌株 A217 产生的抗菌代谢物。
J Appl Microbiol. 2020 Apr;128(4):1143-1152. doi: 10.1111/jam.14548. Epub 2020 Jan 24.
9
Community Structures and Antifungal Activity of Root-Associated Endophytic Actinobacteria in Healthy and Diseased Cucumber Plants and Streptomyces sp. HAAG3-15 as a Promising Biocontrol Agent.健康和患病黄瓜植株中根系内生放线菌的群落结构及抗真菌活性,以及作为有前景的生物防治剂的链霉菌属HAAG3-15
Microorganisms. 2020 Feb 10;8(2):236. doi: 10.3390/microorganisms8020236.
10
Actinoalloteichus nanshanensis sp. nov., isolated from the rhizosphere of a fig tree (Ficus religiosa).南山 actinalloteichus 新种,从无花果树(Ficus religiosa)的根际中分离得到。
Int J Syst Evol Microbiol. 2011 May;61(Pt 5):1165-1169. doi: 10.1099/ijs.0.023283-0. Epub 2010 Jun 18.

引用本文的文献

1
Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review.放线菌次生代谢产物的生物活性及其作为抗肿瘤药物的潜在来源:综述
Front Microbiol. 2025 May 8;16:1550516. doi: 10.3389/fmicb.2025.1550516. eCollection 2025.
2
A Close View of the Production of Bioactive Fungal Metabolites Mediated by Chromatin Modifiers.近距离观察染色质修饰物介导的生物活性真菌代谢产物的产生。
Molecules. 2024 Jul 27;29(15):3536. doi: 10.3390/molecules29153536.
3
Advances on anticancer fungal metabolites: sources, chemical and biological activities in the last decade (2012-2023).抗癌真菌代谢产物的研究进展:过去十年(2012 - 2023年)的来源、化学及生物学活性
Nat Prod Bioprospect. 2024 May 14;14(1):31. doi: 10.1007/s13659-024-00452-0.
4
Screening of marine sediment-derived microorganisms and their bioactive metabolites: a review.海洋沉积物来源微生物及其生物活性代谢产物的筛选:综述
World J Microbiol Biotechnol. 2023 Apr 28;39(7):172. doi: 10.1007/s11274-023-03621-4.
5
Mechanisms of Action of Microbial Biocontrol Agents against .微生物生物防治剂的作用机制针对…… (原文似乎不完整)
J Fungi (Basel). 2021 Dec 6;7(12):1045. doi: 10.3390/jof7121045.

本文引用的文献

1
Actinomycetes isolates of arid zone of Indian Thar Desert and efficacy of their bioactive compounds against human pathogenic bacteria.印度塔尔沙漠干旱区放线菌分离株及其生物活性化合物对人类致病菌的抑菌活性。
Biol Futur. 2021 Dec;72(4):431-440. doi: 10.1007/s42977-021-00073-5. Epub 2021 Feb 2.
2
Sealutomicins, new enediyne antibiotics from the deep-sea actinomycete Nonomuraea sp. MM565M-173N2.深海放线菌 Nonomuraea sp. MM565M-173N2 来源的新型烯二炔类抗生素——海豹霉素。
J Antibiot (Tokyo). 2021 May;74(5):291-299. doi: 10.1038/s41429-020-00402-1. Epub 2021 Feb 3.
3
Novel Macrolactams from a Deep-Sea-Derived Species.深海来源新大环内酯
Mar Drugs. 2020 Dec 29;19(1):13. doi: 10.3390/md19010013.
4
Novel Bioactive Polyketides Isolated from Marine Actinomycetes: An Update Review from 2013 to 2019.新型海洋放线菌来源的生物活性聚酮化合物:2013 至 2019 年的研究进展综述
Chem Biodivers. 2020 Dec;17(12):e2000562. doi: 10.1002/cbdv.202000562. Epub 2020 Nov 18.
5
Bioactive Alkaloids from the Actinomycete sp. ZZ1866.从放线菌 sp. ZZ1866 中分离得到的生物活性生物碱。
J Nat Prod. 2020 Sep 25;83(9):2686-2695. doi: 10.1021/acs.jnatprod.0c00588. Epub 2020 Aug 31.
6
Resistance to Boscalid in From Greenhouse-Grown Tomato.温室番茄中对 Boscalid 的抗性。
Plant Dis. 2021 Mar;105(3):628-635. doi: 10.1094/PDIS-06-20-1191-RE. Epub 2021 Jan 19.
7
An Update on Molecular Tools for Genetic Engineering of Actinomycetes-The Source of Important Antibiotics and Other Valuable Compounds.放线菌的基因工程分子工具最新进展——重要抗生素及其他有价值化合物的来源
Antibiotics (Basel). 2020 Aug 8;9(8):494. doi: 10.3390/antibiotics9080494.
8
New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete sp. SY1965.马里亚纳海沟沉积物来源链霉菌 sp. SY1965 的新型抗真菌代谢产物。
Mar Drugs. 2020 Jul 24;18(8):385. doi: 10.3390/md18080385.
9
Advances in actinomycete research: an ActinoBase review of 2019.放线菌研究进展:ActinoBase 对 2019 年的回顾。
Microbiology (Reading). 2020 Aug;166(8):683-694. doi: 10.1099/mic.0.000944. Epub 2020 Jun 19.
10
Antifungal Activity of Endophyte against in Two Crops.两种作物中内生菌的抗真菌活性
Microorganisms. 2019 Dec 31;8(1):65. doi: 10.3390/microorganisms8010065.

从深海来源的12A22中分离出的次生代谢产物的细胞毒性和抗菌活性。

Cytotoxic and antimicrobial activities of secondary metabolites isolated from the deep-sea-derived 12A22.

作者信息

Zhang Xiaoying, Song Chunfeng, Bai Yan, Hu Jiangchun, Pan Huaqi

机构信息

Institute of Applied Ecology, Chinese Academy of Sciences, South Building Rm 308, 72 Wenhua Road, Shenhe District, Shenyang, 110016 China.

出版信息

3 Biotech. 2021 Jun;11(6):283. doi: 10.1007/s13205-021-02846-0. Epub 2021 May 21.

DOI:10.1007/s13205-021-02846-0
PMID:34094802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8140039/
Abstract

UNLABELLED

A new deep-sea-derived actinomycete 12A22 was isolated from the sediment of the South China Sea which showed potential cytotoxic and antimicrobial activities. The actinomycete was identified as by investigating morphological characteristics and phylogenetic analyses based on its 16S rRNA gene sequence. Two compounds, cyclo-(-Pro--Pro--Tyr--Tyr) () and 2-hydroxyethyl-3-methyl-1,4-naphthoquinone (), were isolated and characterized from the fermentation broth of the strain 12A22. Compound exhibited significant inhibitory activities against a variety of phytopathogenic fungi ( f. sp. , , and ) and Gram-positive bacterium (). In particular, this compound showed better antifungal activity against than positive control amphotericin B. Besides, compound showed moderate cytotoxic activity against human breast cancer MDA-MB-435 cells with IC 10.59 µM, weaker than the positive control diaminedichloroplatinum with 5.91 μM. Our results suggested that this naphthoquinone could be used as a potential antimicrobial and antitumor agent.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13205-021-02846-0.

摘要

未标记

从中国南海沉积物中分离出一种新的深海放线菌12A22,它具有潜在的细胞毒性和抗菌活性。通过对其16S rRNA基因序列进行形态特征研究和系统发育分析,将该放线菌鉴定为[具体名称未给出]。从菌株12A22的发酵液中分离并鉴定出两种化合物,环(-脯氨酸-脯氨酸-酪氨酸-酪氨酸)([化合物名称未完整给出])和2-羟乙基-3-甲基-1,4-萘醌([化合物名称未完整给出])。化合物[未完整给出的化合物名称]对多种植物病原真菌([具体真菌名称未完整给出])和革兰氏阳性菌([具体细菌名称未完整给出])表现出显著的抑制活性。特别是,该化合物对[具体真菌名称未完整给出]的抗真菌活性优于阳性对照两性霉素B。此外,化合物[未完整给出的化合物名称]对人乳腺癌MDA-MB-435细胞显示出中等细胞毒性活性,IC50为10.59 μM,比阳性对照二氯二氨铂(5.91 μM)弱。我们的结果表明,这种萘醌可作为一种潜在的抗菌和抗肿瘤剂。

补充信息

在线版本包含可在10.1007/s13205-021-02846-0获取的补充材料。